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A cobalt-catalyzed combinatorial synthesis of various l3-phenylisoserinederivatives is described. This
methodology is applied to a one-pot synthesis of pyrrolidine- containing a-hydroxyamide core structure,
l3-phenylisoserine-valinedipeptide isostere and a-acetyl- or a-hydroxyethyl-l3-amino acid derivatives.
Inhibition of human immunodeficiency virus type I
(HIV I) protease, an aspartyl protease responsible for
viral maturation and replication, has become an at-
tractive strategy for the design of therapeutic agents
for the treatment': 2 of acquired immune deficiency
syndrome (AIDS). Although HIV protease can
cleave a number of specific peptide bonds, it is un-
usual in being able to cleave the Phe-Pro and Tyr-Pro
sequences found in the gene products. Since the
amide bonds of Pro residues are not susceptible to
cleavage by mammalian endopeptidases, it provides
a basis for rational design of HIV protease inhibitors
selective for the viral enzymes.
The unusual cleavage of Phe-Pro and Tyr-Pro
sequences in gag and gag-pol gene products by HIV
I protease provides a basis for the rational design of
inhibitors for the virus. Many research groups are
actively engaged in developing a series of potent and
selective HIV I protease inhibitors which are de-
signed based on the transition state mimetic concept. 3
Transition state mimetic concept has been applied to
the design and synthesis of non- peptidal small mole-
cules, the peptidomimetics". These small molecules
have emerged as an efficient surrogate for an amide
(Figure I) and their incorporation in a peptide pro-
vides, improved pharmacodynamic properties such
as oral bio-availability and biological half-life. Incor-
poration of peptidomimetic surrogates into bio-ae-
tive molecules has been the focus of intensive
research over the last ten years. Replacement of
proteinogenic amide bonds with suitable conforma-
tionally restricted mimics has the potential to provide









mation of peptides. Conformationally restrained sur-
rogates have been utilized extensively in the design
and the synthesis of enzyme inhibitors, often with
remarkable success. Thus, recent advances have
made it clear that generating libraries of smail-mole-
cule therapeutics offers greater possibilities for mo-
lecular diversity per step with reduced synthetic time
period and effort as compared to linear synthesis. As
a result to this there is a great demand on synthetic
chemists to produce new compounds for testing. One
response to this demand has been the development of
techniques to greatly increase the speed and effi-
ciency of compound synthesis. To address this de-
mand, very powerful chemical and biological
methods 4 have been developed for the generation of
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large combinatorial libraries of small organic mole-
cules. This paper describes the development of new
core structures as mechanism based inhibitors of
my-1 proteases using a combinatorial approach.
my proteases show high specifity for the selec-
tive cleavage of the tyrosine / phenylalanine-proline
amide bonds in the matrix-capsid domain of the
gag-pol polyproteins. It is this sp;cifity that makes
my proteas~ an attractive target for inhibition. The
residues about the cleavage site (tyrosine-proline
bond) at four positions PI-P4 and PI'-P4' for my
protease is shown in Figure 2.
P4 P3 P2 PI PI' P2' P3' P4'
Ser Gin Asn Tyr Pro lie Val Gin
Figure 2
Recent studies have focussed on the development of
small molecules as potential my protease inhibitors
that span P2- Pi subunits in the protein. These efforts
have resulted in the synthesis of mechanism-based
isosteric core structures (Figure 3) such as those of
hydroxyethylamine'v' 1, a-ketoamide8 2 and phos-
phoric acid derivatives 3 4.
The ongoing efforts have resulted in developing
methods that could display a wide range of diverse
functionality about these isosteres. Many of these
inhibitors possess hydrophobic benzyl side chain (the
Pb
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phenylalanine side chains) at PI site, since large
hydrophobic side chains are generally preferred at
this site by the aspartic acid proteases. Recent studies
have demonstrated that the introduction of additional
complimentary groups in the proline ring moiety
results in a significant improvementf in its potency.
It was found that addition of a cis- benzyl ether to C-4
of the proline moiety increases the binding capacity
threefold. The role of keto group in a- ketoamide is
to enhance binding via hydration within the active
site of HIY proteases. The resulting hydrate is then
stabilized through hydrogen bonding interactions/
with the aspartate residues of the enzyme. The hy-
drated form of a- ketoamide is considered to be a
good transition state mimic based on the model
shown in Figure 4.
It is amply clear from these studies that structural
modification in the PI and PI' subunits results in
greater binding of the inhibitors with protease. It is
also evident that hydrophobicity in PI and PI' and
aspartate assisted hydration of a-keto group playa
very dominant role in enhancing this binding. In-
spired by these findings, we have sought to address
two main issues in our current studies. Firstly, how
crucial is the presence of a phenylalanine or tyrosine
residue at PI subunit, and secondly, can we enhance















group out of the main chain and place it as group in
the side chain so that it can be closer to the aspartate
25 and 125. Thus, by replacing benzyl group at C-2
in 4 with phenyl group and placing an acetyl group
instead of a keto at C-3 will give rise to a new
structure 5 where the number of carbon atoms will
not differ greatly and such an inhibitor may possess
the same structural features as that of the u-ke-
toamide (Figure 5).
Similarly, an isosteric relationship can be estab-
lished among the corresponding hydroxy compounds
6 and 7 as the resulting core structure may also have
a similar isostructural relationship, where the hy-
droxyethyl group is placed as a branch u- to the
carbonyl group (Figure 6).
Thus, by bringing isostructural changes in the well
known protease inhibitor, it is possible to create new
structures which will possess the essential features of
the old, one and such a modification may eventually
lead to isosteres with enhanced binding properties. It
is also noteworthy that the relative environment
around C-2 and C-3 of 4 and 6 is not drastically
changed in the modified structures 5 and 7 respec-
tively as the overall requirement for a suitable fit
within the active site of HIV protease is maintained.
With this premise, we have developed a cobalt-cata-
lyzed general route to dipeptide isosteres of 13-
phenylisoserine-valine, proline and IJ- aminoketones
or esters as mechanism based inhibitors of HIV 1
proteases.
Solution Phase Strategy for the Synthesis of
Chemical Libraries Containing I3-Phenylisoser-
ine-Valine and I3-Phenylisoserine-Proline Dipep-
tide Isosters
A wide range of approaches to the §eneration of
chemical libraries have been reported 1 , while solu-
tion phase synthesis has not been widely accepted as
a viable alternative. Inspite of the success achieved
with solid phase- synthesis, there remains few bottle-
necks which can be troublesome ifvery large number
of library members are required. For example, its
scale is generally restricted by the amount of required
solid support and its loading capacity and the prepa-
ration of muItimiligram quantaties of each library can
be cumbersome and expensive. The solution phase
chemistry is emerging 11 as an important complement
to solid phase combinatorial synthesis mainly due to
the techniques developed for the isolation of pure
compounds based on liquid- liquid or solid-liquid
extraction. We have persued a solution phase tech-
nique in our approach to the synthesis of dipeptide
isosteres.
Earlier studies from our group have demon-
strated 12 that alkenes can be epoxidized with dioxy-
gen in the presence of a catalytic amount of cobalt
complexes. We have also shown that epoxides can be
cleaved 13 with anilines under the catalytic action of
CoCh at ambient conditions. We have adopted a
combined application 14 of cobalt-catalyzed epoxida-
tion followed by cleavage with anilines for the gen-
eration of functionally diverse I3-phenylisoserines.
Thus, treatment of ethyl cinnamate with 2- methyl-
propanal in acetonitrile under aerobic conditions in
the presence of a catalytic amount of cobalt(III)-
DMG complex at ambient conditions afforded the
corresponding epoxide in good yields. This epoxide
was then reacted with ani lines and its derivatives in
the presence of catalytic CoCh in acetonitrile at
ambient conditions to afford the corresponding anti-
I3-phenylisoserine derivatives in high yields
(Scheme I).
The corresponding syn-diastereomers were also
obtained in around 5 to 10% yields. The products
were initially purified by column chromatography;
however, our later attempts succeeded in isolating
them by fractional crystallization. The versatility of
this cobalt-catalyzed protocol was demonstrated by
the preparation of a set of library containing ten
distinct isoserine derivatives as shown in Scheme II.
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Our efforts on the modification of catalyst resulted
in the discovery of polyaniline supported cobalt com-
plexes which proved to be efficient15 during epoxi-
dation as well as cleavage with ani lines. This led to
the development of a one-pot procedure for the con-
version of cinnamates or cinnamoyl amides to the
corresponding J3-phenylisoserine derivatives. The
polyaniline supported cobalt complexes were pre-
pared by mixing cobalt acetate or cobalt salen with
polyemarldene base in mixed solvent system of ace-
tonitrile / acetic acid at ambient conditions (Figure
7).
Typically, cinnamoyl amide (5 mmoles), 2-
methylpropanal (15 mmoles) and (P)-Co(OAC)2
were taken in acetonitrile and the mixture was stirred
at room temperature under dioxygen balloon for 5 to
8 hr. The progress of the reaction was monitored by
TLC and as soon as the starting olefin disappeared
the oxygen balloon was removed and aniline (7.5
mmoles) or its derivative added, and the resulting
Scheme II
Polyemarldene + Co(OAe)2 AeOH. ~ Co(OAe12
MeCNPolyemarldene + Co(Salen) _ ®- Co(Salen)
Fit. 7
mixture stirred at ambient temperature for another 5
to 6 hr. The solvent was removed to afford a semi-
solid which was washed few times with CCl4 to
afford a colourless solid in good purity (Scheme III).
This protocol circumvents the purification process
by column chromatography and in most cases the
purity of solid was found to be greater than 90%. This
methodology was used to prepare a set of library
containing fourteen distinct isoserine derivatives as
shown in Scheme rv. It is interesting to note that this
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Scheme IV
tide isosteres of J3-phenylisoserine and valine / yields (Scheme V). HPLC analysis of these products
proline and as per this protocol a set of ten distinct indicated them to be a single anti-diastereomers;
compounds were prepared from the amide deriva- however, the absolute configuration of the chiral
tives of proline / valine and hydroxy proline in good centre present in them could not be ascertained. We
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are currently pursuing studies to unambiguously as-
sign the absolute stereochemistry to these chiral cen-
tres.
Multiple Component Condensation Protocol
for the Synthesis of ~Acetamido-ketones or Es-
ters
Multiple component condensations are those reac-
tions in which three or more reactants come together
in a single reaction vessel to form a new product
which contains portions of all the components. This
strategy has been used for the generation of a library
of a compounds using Ugi 10 or Passerini4 reaction.
We have sought to pursue a similar approach using a
cobalt-catalyzed three component coupling proce-







balt(II) chloride catalyzes the coupling of a ketone or
ketoester, aldehyde and acetonitrile in the presence
of acetyl chloride to afford a high yield of r>-
acetamido-ketones or esters as shown in Scheme VI.
A variety of ketones or ketoe-sters and aldehydes
were coupled in acetonitrile to afford a diverse set of
r>-acetamido ketones or esters. A library of thirty two
such compounds was obtained using this protocol
(Scheme VII). In most of the cases the corresponding
anti-r>-acetamido-ketones were obtained as the major
product.
The procedure for their isolation is very simple as
most of these compounds can be isolated by passing
diem over a silica gel column. However, our attempts
are on to purify them by a solvent extraction proce-
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Scheme VIII
dure. The J3-acetamido esters were reduced by
NaBH4 to afford the corresponding compounds
(Scheme VIII) containing a hydroxyethyl side chain.
These alcohols thus possess the core structure 7 (Fig-
Scheme VII
ure 6) which can be incorporated in an amino acid
residue to afford the corresponding peptide isosteres.
In conclusion, the studies described herein illus-
trate a highly versatile protocol for a cobalt-catalyzed
three component condensation to afford a library of
compounds containing J3-phenylisoserine derived
dipeptide isosteres and J3-acetamido-ketones as po-
tential HIV 1 protease inhibitors. The procedure for
the synthesis of these compounds is very simple as in
each reaction the final products were subjected to
simple purification by liquid-liquid or liquid-solid
extraction to remove reactants, unreacted starting
materials, reagents and their byproducts providing a
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library of compounds in purity irrespective of the
reaction yield and without reaction optimization.
Experimental Section
General. Acetonitrile, acetic acid, carbon tetra-
chloride, 2- methylpropanal, olefins, different alde-
hydes, ketones, keto- esters, aniline and its
derivatives and other solvents, reagents were used
after purification according to the standard proce-
dure. CoCh was purchased from LOBA India Ltd.,
Bombay, and dried at 110°C for 2 to 3 hr before the
reaction. Co(OAc)2 was purchased from E. Merk,
India Ltd. Co(III)DMG and Co-Salen complexes
were prepared according to the literature procedure.
Column chromatography was performed using 60-
120 mesh (ACME) TLC silica gel or neutral alumina.
IHNMR spectra were recorded at 60, 80 and 400
MHz in CDCh, DMSO-d6 or CCl4 using TMS as
internal standard. All the starting materials were pre-
pared according to literature procedures and com-
pared with their 1HNMR spectra. All the products
were characterized by comparing with the literature
data or by comparing with melting points.
General procedure for the Co-catalyzed syn-
thesis of ~acetamido-ketones or esters. Aldehyde
00 mmoles), ~ketoester (10 mmoles) and acetyl
chloride (20 mmoles) were added to a stirred solution
of CoCh (10 mg) in dry acetonitrile (SO mL). The
resulting mixture was heated at 80 to 8SoC for 12 to
14 hr and the progress of the reaction was monitered
by TLC. The solvent was evaporated in vacuo and
the residue taken in SO mL of ethyl acetate. The
organic layer was successively washed with Na-
HC03 (3xSO' mL), brine (lx2S mL) and water
(2SmL). Drying (over MgS04) followed by evapora-
tion of solvent gave the crude product which was
purified by column chromatography (408r0 EtOAc in
hexane).
Preparation of cobalt(II)-supported polyanil-
ine catalyst. A mixture of polyaniline and cobalt(II)
acetate (1: 1, w/w) was stirred in acetonitrile and
acetic acid (1: 1, v/v) for 72 hr at room temperature.
The reaction mixture was filtered and solid catalyst
washed with acetonitrile till the filtrate became col-
ourless. The catalyst was dried at 110 to 120°C.
Preparation of polyaniline-supported co-
balt(lI)-salen catalyst. A mixture of polyaniline and
cobalt salen (1: 1, w/w) was stirred in acetonitrile for
36 hr at room temperature. The reaction mixture was
filtered and the solid catalyst washed with acetoni-
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trile and acetic acid till the filtrate became colourless.
The catalyst was dried at 110 to 120°C.
General procedure for synthesis of ~
pbenylisoserine derivatives. A mixture of cin-
namoyl amide (S mmoles) was dissolved in
acetonitrile and 2-methylpropanal (15 mmoles)
added to it, and the resulting mixture stirred in the
presence of a catalytic amount of polyaniline sup-
ported cobalt(II)-salen under oxygen atmosphere at
ambient temperature for 16 to 22 hr. The progress of
the reaction was monitered by TLC. As soon as the
starting cinnamoyl amides disappeared the oxygen
balloon was removed and anilines (S mmoles) and a
small amount of catalyst were added to this reaction
mixture. The mixture was stirred at 2SoC for 6 to 8
hr. Removal of solvent gave a residue which was
washed with CC 14 (3 x l 0 mL) to afford the 13-
phenylisoserine derivatives as crystalline solids.
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